Tag: AbbVie Inc

Finance

Market Movers: AbbVie Inc. (NYSE:ABBV), Xerox Corporation (NYSE:XRX), SunTrust Banks (NYSE:STI), Danaher Corp. (NYSE:DHR), Eagle Bancorp Montana, Inc. (NASDAQ:EBMT)

AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 21.70% and weekly performance is 1.16%. On last trading day company shares ended up $55.60. AbbVie Inc. (NYSE:ABBV) distance from 50-day simple moving average (SMA50) is 2.25%. One such investor is Robert Zapfel. He is the President of Services Business at Xerox Corp. (NYSE:XRX). On Augusts 7th, Mr. Zapfel bought 40,000 XRX shares at … Continue reading Market Movers: AbbVie Inc. (NYSE:ABBV), Xerox Corporation (NYSE:XRX), SunTrust Banks (NYSE:STI), Danaher Corp. (NYSE:DHR), Eagle Bancorp Montana, Inc. (NASDAQ:EBMT)

Jason Knox
Finance

Eye Catching Stocks: AbbVie Inc. (NYSE:ABBV), DepoMed Inc. (NASDAQ:DEPO), Misonix Inc. (NASDAQ:MSON), Bebe Stores, Inc. (NASDAQ:BEBE)

AbbVie (NASDAQ:ABBV) had its target price boosted by Credit Suisse from $60.00 to $63.00 in a report issued on Wednesday. They currently have an outperform rating on the stock.AbbVie Inc. (NYSE:ABBV) shares moved down -0.21% in last trading session and ended the day at $55.75. ABBV Gross Margin is 76.40% and its return on assets is 14.50%. AbbVie Inc. (NYSE:ABBV) quarterly performance is 3.89%. DepoMed Inc. … Continue reading Eye Catching Stocks: AbbVie Inc. (NYSE:ABBV), DepoMed Inc. (NASDAQ:DEPO), Misonix Inc. (NASDAQ:MSON), Bebe Stores, Inc. (NASDAQ:BEBE)

Kristen Barton
BioTech, Finance

Shire Rejects a $46.5 Billion AbbVie (NYSE:ABBV) Takeover Offer

Goldman Sachs has been hired by Shire as the London-listed drug maker confronts a takeover offer, as explained in the Financial Times morning briefing. Shire turned down a $46 billion bid from Chicago-based AbbVie last week. According to a report from the New-York Times, people briefed on the matter said AbbVie was likely to come back with a higher offer. Allergan, which is fending off … Continue reading Shire Rejects a $46.5 Billion AbbVie (NYSE:ABBV) Takeover Offer

Harvey Dyer
Finance

Hot Stocks: VMware, Inc. (NYSE:VMW), Honeywell International Inc. (NYSE:HON), AbbVie Inc (NYSE:ABBV), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

VMware, Inc (NYSE:VMW) COO Carl M. Eschenbach unloaded 5,897 shares of the stock in a transaction dated Wednesday, May 21st. The shares were sold at an average price of $95.05, for a total value of $560,509.85. Following the sale, the chief operating officer now directly owns 81,879 shares of the company’s stock, valued at approximately $7,782,599. VMware, Inc. (NYSE:VMW) stock performance was 1.54% in last … Continue reading Hot Stocks: VMware, Inc. (NYSE:VMW), Honeywell International Inc. (NYSE:HON), AbbVie Inc (NYSE:ABBV), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Richard Atkins
Finance

Market Movers: AbbVie Inc. (NYSE:ABBV), Morgan Stanley (NYSE:MS), Sanmina Corporation (NASDAQ:SANM), Advanced Semiconductor Engineering Inc. (NYSE:ASX), Resource Capital Corp. (NYSE:RSO)

AbbVie Inc. (NYSE:ABBV) rival Gilead makes exclusive deal with CVS for hep C drugs. The deal blocks North Chicago-based AbbVie Inc.’s treatment, called Viekira Pak, which will only be available to patients given approval because of medical exceptions or through a process called prior authorization, according to CVS. Patients already taking Viekira Pak will be allowed to finish their treatment. AbbVie Inc. (NYSE:ABBV) belongs to … Continue reading Market Movers: AbbVie Inc. (NYSE:ABBV), Morgan Stanley (NYSE:MS), Sanmina Corporation (NASDAQ:SANM), Advanced Semiconductor Engineering Inc. (NYSE:ASX), Resource Capital Corp. (NYSE:RSO)

Richard Atkins